Cargando…
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
We aimed to create a prognostic model in metastatic melanoma based on independent prognostic factors in 321 patients receiving interleukin-2 (IL-2)-based immunotherapy with a median follow-up time for patients currently alive of 52 months (range 15–189 months). The patients were treated as part of s...
Autores principales: | Schmidt, H, Bastholt, L, Geertsen, P, Christensen, I J, Larsen, S, Gehl, J, von der Maase, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361564/ https://www.ncbi.nlm.nih.gov/pubmed/16052222 http://dx.doi.org/10.1038/sj.bjc.6602702 |
Ejemplares similares
-
Monocytes and neutrophils as ‘bad guys’ for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma – results from a randomised phase II trial
por: Donskov, F, et al.
Publicado: (2006) -
Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014) -
Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma
por: Geertsen, P F, et al.
Publicado: (2004) -
Elevated neutrophil - to - monocyte ratio as a prognostic marker for poor outcomes in neonatal sepsis
por: Xia, Xiaohong, et al.
Publicado: (2022) -
Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta‐analysis, and meta‐regression
por: Wen, Shu, et al.
Publicado: (2021)